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Collagen is significantly upregulated in colorectal liver metastasis (CRLM) compared
to liver tissue. Expression levels of specific collagen types in CRLM resemble those
in colorectal cancer (CRC) and colon tissue. We investigated whether the collagen
hydroxylation pattern from the primary tumor also migrates with the metastatic tumor.
The degree of collagen alpha-1(I) hydroxylation in colon, CRC, liver, and CRLM tissue
of the same individuals (n = 14) was studied with mass spectrometry. The degree of
hydroxylation was investigated in 36 collagen alpha-1(I) peptides, covering 54% of the
triple helical region. The degree of hydroxylation in liver tissue was similar to that in
colon tissue. The overall degree of hydroxylation was significantly lower (9 ± 14%) in
CRC tissue and also significantly lower (12 ± 22%) in CRLM tissue compared to colon.
Furthermore, eleven peptides with a specific number of hydroxylations are significantly
different between CRLM and liver tissue; these peptides could be candidates for the
detection of CRLM. For one of these eleven peptides, a matching naturally occurring
peptide in urine has been identified as being significantly different between patients
suffering from CRLM and healthy controls. The hydroxylation pattern in CRLM resembles
partly the pattern in liver, primary colorectal cancer and colon.
Keywords: post-translational modification, mass spectrometry, colorectal cancer, colorectal liver metastasis,
collagen, hydroxyproline
INTRODUCTION
Collagen is a family of proteins that form triple helical structures. A triple helix is formed by three
protein subunits called alpha-chains. The specific part of an alpha-chain involved in triple helix
formation consists of a repeating unit [-Gly-Xaa-Yaa-]n where Xaa and Yaa can be different amino
acids, frequently proline and lysine (1). Proline and lysine can be enzymatically modified prior
to triple helix formation. Proline is hydroxylated into hydroxyproline (Hyp); two different Hyp
isomers exist in collagen, namely 4-hydroxyproline (4Hyp) and—more rarely—3-hydroxyproline
(3Hyp). Normally, 4Hyp at the Yaa-position is formed by 4-prolyl hydroxylase, which requires
Gly-Xaa-Pro as substrate (2). 4-hydroxyproline rarely occurs at the Xaa positions (4xHyp), neither
the enzyme, nor the substrate required for the formation of 4xHyp is known (3). 3Hyp is formed by
3-prolyl hydroxylase, which requires Gly-Pro-4Hyp as substrate (4). 3Hyp and 4Hyp are involved
in triple helix stability and fiber formation, but their specific functions are still not fully understood
(5–7). The function of 4xHyp remains unknown (3). Lysine can be modified into 5-hydroxylysine
van Huizen et al. Reduced Collagen Hydroxylation in Cancer
(5Hyl) by lysyl hydroxylases (8). In addition, 5Hyl can be further
glycosylated (9) and is involved in collagen cross-linking (10).
After triple helix formation, collagen triple helices are excreted
from the cell via the Golgi apparatus into the extracellular
matrix. In the extracellular matrix, triple helices form a variety
of supramolecular structures (11).
Triple helix folding is reversible; unfolding occurs when
the melting temperature (Tm) is exceeded (12). The Tm is
influenced by the physical properties of the amino acids at the
Xaa and Yaa positions (1) and post-translational modifications
(PTMs). In short model peptides, hydroxylation of proline into
4Hyp increased the Tm up to 6
◦
C, while conversion into 3Hyp
decreased the Tm (6). The effect of 5Hyl on the Tm remains
unknown. Leikina et al. (13) demonstrate that the Tm of collagen
type I in lung is just below body temperature, in addition, only
folded triple helices are present below 30
◦
C. If the number of
PTM’s decreases, then this would result in collagen with a lower
Tm. Collagen with a lower Tm will unfold/melt before it can be
built into fibers and will be degraded by the body.
The 4Hyp formation rate is influenced by the amino acid at the
Xaa position (14), the temperature at which collagen-producing
cells are cultured (15), and the amount of oxygen present (16).
Collagen produced under hypoxic conditions has∼1.7% less Hyp
and almost 10% less Hyl (16). Under hypoxic conditions, proline
hydroxylation is the rate limiting step of collagen formation,
indicating that a minimum number of PTMs is required to form
stable collagen. Because collagen hydroxylation is influenced by
many parameters, we hypothesize that the hydroxylation pattern
varies strongly between different tissues and within a particular
tissue. In agreement with this, Montgomery et al. (17) described
that the degree of hydroxylation in collagen alpha-1(I) of ten
breast cancer patients varied between 0 and 90%, depending on
the proline position.
Collagen levels in tumor tissue are dysregulated in comparison
to healthy tissue (18). In colorectal liver metastasis (CRLM),
collagen levels are, in general, significantly upregulated in
comparison to adjacent normal liver tissue (19, 20). Collagen type
10, 12, 14, and 15 expression levels have most likely migrated
from the healthy colon tissue, via the primary tumor (colorectal
cancer; CRC), to the metastasis. The migration of colon-specific
protein expression into CRLM is not limited to collagen; other
proteins, e.g., CDH17, KRT20, CEACAM5, GPA33, MUC13,
and PPP1R1B/DARPP32 show a similar pattern, although many
colon-specific proteins are down-regulated too (20).
In this study, we have investigated the hydroxylation pattern,
taking into account the hydroxylation of proline and lysine in
collagen alpha-1(I), to better understand the changes in collagen
caused by CRLM.We hypothesize that the hydroxylation pattern
co-migrates from colon tissue, via the primary tumor, toward
the metastasis similarly as a number of colon-specific proteins
and specific collagen types. In addition, it was investigated if
Abbreviations: 3Hyp, 3-hydroxyproline; 4Hyp, 4-hydroxyproline; 4xHyp,
4-hydroxyproline at the Xaa-position; CRC, Colorectal cancer; CRLM,
Colorectal liver metastasis; Hyp, Hydroxyproline; IQR, Interquartile range;
NOP, Natural occurring peptides; pO2, Partial pressure of oxygen; Tm, Melting
temperature of collagen.
studying the collagen hydroxylation pattern can aid in the finding
of biomarkers to further improve the diagnoses of CRLM based
on urine (21). Collagen hydroxylation was studied with bottom-
up mass spectrometry in colon, CRC, CRLM, and liver tissue
obtained from the same individual.
MATERIALS AND METHODS
Sample Selection
Bottom-up proteomics data of matching normal liver tissue and
colorectal liver metastasis (CRLM) tissue of 30 patients were
retrieved from the PRIDE Archive (PXD008383). Normal liver
tissue was taken at least 1 cm away from the tumor (20). We
could collect matching healthy adjacent colon tissue and CRC
tissue from 14 out of these 30 patients. The tissue material had
been collected during curative surgery. Morphology differences
indicated that the CRC tissues contained adjacent normal tissue,
and that one colon tissue contained tumorous tissue. None
of the CRLM tissues contained non-tumor material, and none
of the liver tissues contained non-normal tissue. This study
was approved by the Erasmus MC ethics review board (MEC-
2007-088) and we have worked according to the declaration
of Helsinki. An experienced pathologist (MD) has reviewed
the sections.
Sample Preparation and Data Processing
All tissues were prepared, measured, and data processed as
described by van Huizen et al. (20). In short, formalin cross-
links were removed by incubation with 1M TRIS pH 8, followed
by cysteine reduction and alkylation. The proteins in the tissue
were cleaved into peptides by overnight incubation with trypsin,
0.6 µg of trypsin was added. Trypsin cleaves after lysine and
arginine except if a proline is present after these two amino acids.
Peptides were identified with nanoLC-MS/MS measurements on
an Orbitrap Fusion Tribrid Mass Spectrometer (Thermo Fischer
Scientific, San Jose, CA, USA). MGF peak list files were extracted
from raw files by ProteoWizard (v3.0.9166) and searched with
Mascot (v2.3.2, Matrix Science Inc., London, UK) and the
UniProt/Swiss-prot Human database (20,194 entries, v2015_11).
Hydroxylations (+16 Da) of proline, lysine, andmethionine were
included as variable modifications and carbamidomethylation
(+57 Da) of cysteine as fixed modification. A maximum of 4
missed cleavages was allowed. Mascot search results were further
analyzed in Scaffold (v4.6.2, Portland, OR, USA). In Scaffold,
protein confidence levels were set to a 1% false discovery rate
(FDR), at least 2 peptides per protein, and a 1% FDR at the
peptide level. FDRs were estimated by inclusion of a decoy
database search generated by Mascot. A Peptide Report exported
from Scaffold was used for data analysis. The peptide report
regarding liver and CRLM tissue has been published (20), the
peptide report regarding colon and CRC tissue is included in the
Supplementary S1. Mass spectrometry data was made publicly
accessible via the PRIDE archive, accession number: PXD015015.
Peptide Panel Selection
Collagen alpha-1(I) peptides were selected on the following
criteria: (1) does not contain methionine or cysteine; (2) contains
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at least one proline or lysine moiety; and (3) a unique number
of hydroxylations, having been identified in 20 or more liver or
CRLM tissues, and in 3 or more colon and CRC tissues. The latter
sub criterion was applied because the statistical formulas used
require a sample size of 3 or larger.
Principal Components Analysis
Principal component analysis (PCA) was performed in R (v3.6.0.)
(22); the R-script can be found in the Supplementary S2. A
table was created containing for every sample a value for the
absence (value 0) or presence (value 1) for each peptide with
a unique number of hydroxylations. Zero to 10 hydroxylations
were taken into consideration; where 10 is the maximum number
of hydroxylations observed for the peptides in the peptide panel.
The PCA was calculated with the “prcomp” function. If two
or more tissue types were compared, then a 2D-PCA-plot was
made with the package “factoextra.” 3D-PCA-plots were made by
exporting the coordinates of the first three PCA dimensions, and
plotting with “scatter3d.” For assessment of the data, 2D-PCA-
plots were made by exporting the PCA coordinates, and plotting
with “ggplot2.”
Hydroxylation Analysis
Statistical analysis was performed in R (v3.6.0.) (22), the R-
script can be found in the Supplementary S3. In the digested
tissue, collagen peptides are present with different numbers of
hydroxylations per peptide. A difficulty with collagen analysis
is the identification of the exact location of a hydroxylation. To
avoid the identification of the exact hydroxylation position, we
used the number of hydroxylations per peptide obtained by the
parent mass. Per tissue type (n= 4), per patient (n= 14 and n=
30), and per peptide from the peptide panel (n= 36), we checked
the presence of 0 to 10 hydroxylations taking into account
both hydroxyproline and hydroxylysine, which generated a
three-dimensional data matrix. Per peptide a list was generated
containing the numbers of different forms observed, compared
between two tissue types. Testing for differences between tissue
types was performed with a paired Wilcoxon signed-rank test.
Per tissue a list was generated containing the average number
of hydroxylations per peptide, which was compared between two
tissue types with a paired Wilcoxon signed-rank test. If a peptide
was not identified in tissue from a particular patient, no average
could be calculated, then this patient was removed from analysis
of the average number of hydroxylations. Besides the overall
differences between the number of different forms observed,
and the average number of hydroxylations per peptide, we also
studied in more detail if there are peptides with a specific number
of hydroxylations that is different between different tissues. The
difference in a specific hydroxylation form between two tissue
types was assessed with the McNemar test. Two-sided p-values
below 0.05 were considered as significant. Figure 1 shows an
example of the set-up of the data.
Data Assessment
The quality of the data was assessed prior to the analysis of
collagen hydroxylation. A bias in the data based on patient
characteristics (age and gender) was investigated by making 2D-
PCA plots per tissue type. For cancerous tissue also the location
of the primary tumor was taken into account. Furthermore, colon
and CRC tissue contained non-normal and non-tumor tissue,
respectively. Therefore, an additional 2D-PCA-plot was made
containing colon and CRC tissue to assess the presence of a bias
based on the percentage of non-normal and non-tumor tissue.
Permutation testing (i.e., randomly reassigning samples
to the groups) was used to estimate background in the
distribution of the number of forms, the average number
of hydroxylations and specific hydroxylation forms between
different tissue types. For each peptide, the distribution of
the number of forms, the average number of hydroxylations
and specific hydroxylation forms was compared between liver
and CRLM (both n = 30 and n = 14) and between other
pairs of organs (n = 14) using a paired Wilcoxon signed-
rank test with a critical p-value of 0.05. To demonstrate the
significant differences present between the unpermitted data
(i.e., the true data), the permutation results were used as a
test statistic. The critical value of the permutation test was
calculated as the 95th percentile of the number of peptides
with a significant difference when samples were permutated.
The significance of the number of differences found in the
unpermitted data was expressed as a p-value. This p-value
was calculated as the proportion of the permutations where
the number of peptides with a significant difference was at
least as large as in the unpermitted data. The test used 1,000
random permutations.
Presence of linear relation between the number of forms and
the average number of hydroxylations was tested per tissue with
the Pearson correlation test. A linear relation was considered
significant if the p-value was below 0.05/4 = 0.0125 (Bonferroni
correction for multiple testing, n= 4).
Analysis of the Hydroxylation Variation
The hydroxylation pattern was compared between: colon and
liver, colon and CRC, CRC, and CRLM, colon and CRLM, and
liver and CRLM. The difference in the degree of hydroxylation
was analyzed in different directions: (1) 2D- and 3D-PCA-plots;
(2) the number of forms observed; (3) detailed analyzes of the
average number of hydroxylations; and (4) analyses of a specific
hydroxylation form. Detailed information regarding the average
number of hydroxylations was obtained by: plotting the average
number of hydroxylations per peptide; the absolute difference
in the average number of hydroxylations per peptide of CRC,
CRLM, and liver tissue with respect to colon tissue (tissue—colon
tissue); and the relative difference with respect to colon tissue
([tissue/colon −1]∗100%). Differences between all groups were
tested with independent samples t-tests. For the average number
of hydroxylations per peptide, p-values below 0.05/6 (Bonferroni
correction, 6 comparisons), and for the relative differences, p-
values below 0.05/3 (Bonferroni correction, 3 comparisons) were
considered significant. The average of the relative difference
was compared to zero with a one-sample t-test; p-values below
0.05/3 (Bonferroni correction, 3 comparisons) were considered
as significant.
Frontiers in Oncology | www.frontiersin.org 3 September 2020 | Volume 10 | Article 557737
van Huizen et al. Reduced Collagen Hydroxylation in Cancer
FIGURE 1 | A diagram explaining the data analysis. Per tissue, per patient the number of forms present in collagen peptides, and the average number of
hydroxylations per peptide is determined (blue and yellow tables). Per peptide, per patient these two values are compared between two tissue types, left and middle
green table. In addition, every form (specific hydroxylation) is separately compared between two tissue types based on the number of patients in which the specific
form is identified, right green table.
Urine Analysis
The value of the significant different peptides identified in section
Analysis of the Hydroxylation Variation as a biomarker has been
investigated by reanalyzing the published data (PXD013533) by
van Huizen et al. (21). The bottom-up mass spectrometry data
was processed as described by van Huizen et al., whereby we
considered a peptide as significant when a p-value was below 0.05.
RESULTS
Patient Characteristics
An overview of all patient characteristics is present in
Supplementary S4. CRC patients (n = 14) had a median age of
64 years [interquartile range [IQR] 57–73] and were mostly male
(64%). The CRC tumor had a median size of 4.0 cm (IQR 3.3–
4.8), being moderately differentiated adenocarcinomas. CRC was
located in rectum (64%, 9 out of 14) or sigmoid (36%, 5 out of 14).
Liver and CRLM tissue were not collected simultaneously with
colon and CRC tissue. The CRLM patients had a median age of
65 years (IQR 59–73) and a median of 2 (maximum 7) tumors
with a median size of 2.3 cm (IQR 1.2–3.5), being moderately
differentiated adenocarcinomas.
Prior to surgical removal of CRC or CRLM some patients
have received pretreatment in the form of chemotherapy (CRC
= 0, CRLM = 6), or a combination of chemotherapy and
radiotherapy (CRC = 2, CRLM = 1). In Supplementary S5, we
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have investigated if a clustering based on the pretreatment is
present in a 2D-PCA-plot, and we did not observe a correlation.
In some patients molecular diagnostics has been performed
on the CRC (n = 7) or CRLM (n = 4). Only in three of
the seven CRC tumor tissues on which molecular diagnostics
has been performed are included in this research (n = 3). In
Supplementary S5, we have investigated if a clustering in 2D-
PCA-plot based on the results of the molecular diagnostics is
present, and we did not observe a correlation.
Peptide Selection
All tissue samples were digested with trypsin and measured via
a proteomics bottom-up approach. Mass spectra were searched
against the Uniprot/Swissprot human protein database, having
hydroxylation of proline and lysine as a variable modification.
The database search resulted in the significant identification of,
among others, collagen alpha-1(I) peptides.
The number of identified collagen alpha-1(I) peptides with
unique numbers of hydroxylation differed per tissue type
(ANOVA p < 0.001), only colon and CRC were not significantly
different (Bonferroni post-hoc testing p > 0.05) and all other
comparisons were significantly different (Bonferroni post-hoc
testing p < 0.0001). The following average numbers of peptides
with unique number of hydroxylations were identified in liver 70
(n = 30, SD=17), CRLM 111 (n = 30, SD = 23), colon 162 (n
= 14, SD = 10), and CRC 168 (n = 14, SD = 28). A total of 113
different peptides with a unique number of hydroxylations were
identified, which did neither contain methionine nor cysteine.
From these 113 peptides a panel of peptides was selected based on
the following selection criteria: (1) does not contain methionine
or cysteine; (2) contains at least one proline or lysine moiety; (3)
a specific number of hydroxylations in a specific collagen peptide
ought to be identified in 20 or more liver or CRLM tissues,
and in 3 or more colon and CRC tissues. Thirty-six peptides
fulfilled all selection criteria These 36 peptides covered 54% of the
triple helical region of collagen alpha-1(I), Supplementary S5.
They are ranked corresponding to their occurrence in the
primary structure of collagen, and will be referred in the text
as, for example, peptide 1. Supplementary S5 also contains per
tissue a table specifying the number of hydroxylations on the
peptides present.
Data Assessment
Prior to analysis of the collagen hydroxylation pattern, the data
was assessed to investigate if any bias is present in the data that
would indicate that the degree of hydroxylation is related to a
patient characteristic. Data assessment was performed by making
2D-PCA-plots and a permutation test.
In the constructed 2D-PCA-plots we investigated if a relation
between the collagen hydroxylation and patient characteristics
was present (Supplementary S5). The 2D-PCA-plot is based
on the absence or presence of a peptide with a specific
number of hydroxylations. The patient characteristics are
visualized by specific shapes, colors, and different sizes of the
data points. The axes of the 2D-PCA-plots describe the first
and second dimension variability of the first two principal
components (PC).
The degree of collagen hydroxylation in CRLM and CRC
tissue showed no clustering based on patient age, gender,
or location of the (primary) tumor. Likewise, the degree of
hydroxylation in liver and colon tissue showed, based on 2D-
PCA-plots, no clustering based on patient age or gender. All
CRC tissues contained to some extent normal tissue, and just
one colon tissue contained some tumorous tissue. Nevertheless,
colon and CRC samples still clustered based on the tissue type.
The 2D-PCA-plots are available in the Supplementary S5.
Permutation testing results are presented in Figure 2.
The permutation test indicates that, differences between two
tissue types are significant (p < 0.05) if more than 4
differences in the number of forms, 3 differences between
the average number of hydroxylations per peptide, or 4
specific hydroxylation forms are found. In all comparisons
more significant differences were present than expected by
permutation testing. The within tissue variation in liver and
CRLM tissue is similar to the number of differences observed
by chance between the different tissue comparisons, indicating
that the differences between tissue are significantly larger than
within a tissue.
Tissue Comparison
In the 2D-PCA-plot shown in Figure 3, liver, CRLM, and colon
are separated based on their hydroxylation pattern. CRC is
separated from liver and CRLM tissue, but overlaps with colon
tissue. Two exceptions are observed. Patient CRLM-10 is located
(coordinates: −3.98, 0.22) in between the liver samples, most
likely because only 23 different peptides with a unique number
of hydroxylations were identified (liver average = 62). Patient
CRC-19 is located (coordinates: −1.01, 0.38) in between the
liver samples, because only 69 different peptides with a unique
number of hydroxylations were identified (CRC average = 92).
A 3D-PCA-plot based on the first three dimensions results in
a complete separation between liver, CRLM, and Colon+CRC,
while colon and CRC are still partly overlapping. The 3D-PCA-
plot is available in the Supplementary S5. The 2D-PCA-plots and
3D-PCA-plots for individual tissue comparisons are also available
in the Supplementary S5. For the comparison “liver vs. colon,”
there is a complete separation in a 2D-PCA-plot and 3D-PCA-
plot. For “colon vs. CRC” there is a partial overlap in the 2D-
PCA-plot and 3D-PCA-plot. For “CRC vs. CRLM,” and “liver
vs. CRLM” (14 vs. 14) there is a slight overlap in the 2D-PCA-
plot and they are fully separated in the 3D-PCA-plot. “Liver vs.
CRLM” (30 vs. 30) are partly overlapping in the 2D-PCA-plot,
and fully separated in the 3D-PCA-plot.
An overview of the results of the tissue comparisons based
on the number of forms, average number of hydroxylations,
and specific hydroxylations is presented in Figure 2. A Pearson
correlation test was performed to exclude a relation between the
number of different forms observed and the average number
of hydroxylations per peptide. Significant correlations were not
found (p-critical= 0.05/4= 0.0125, Bonferroni correction); liver:
r= 0.40, p= 0.018 CRLM: r= 0.31, p= 0.066; colon: r= 0.21, p
= 0.21; CRC: r= 0.16, p= 0.35.
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FIGURE 2 | Tissue comparison analysis. The black table shows the number of peptides down- or upregulation regarding the differences in the number of forms, the
average number of hydroxylations, and specific hydroxylations. The arrows indicate the comparisons made and tables surrounding the tissue cartoons having the
same color belong together. Reprinted (adapted) with permission from (21). Copyright (2019) American Chemical Society.
The number of significant peptides and the direction (down-
or upregulated) indicate the similarity between the different
tissue types. It is worth noting that colon and lover tissue show
the highest difference in the average number of hydroxylations,
although it is equally down- and upregulated. While colon and
CRC have only 11 significant differences in the average number
of hydroxylations, the degree of hydroxylation is strongly
downregulated in CRC tissue. Also between CRC andCRLMonly
11 significant differences were present in the average number of
hydroxylations, however in this case they are more equally down-
and upregulated.
To compare the effect of group size, the comparison “liver vs.
CRLM”was performedwith the patients of whom colon andCRC
tissue was collected (14 vs. 14) and with the full data set (30 vs.
30). As expected, in the full data set, more and stronger significant
differences were observed, because more samples result in a
better powered analysis.
In all tissue comparisons the total number of significant
differences with respect to the average number of hydroxylations
is similar. However, the comparisons of “liver vs. colon,”
and “CRC vs. CRLM” have a similar number of down-
and upregulated averages (black table Figure 3), while the
comparisons “colon vs. CRC,” “colon vs. CRLM,” and “liver
vs. CRLM” have an overall increase in downregulation of
the average.
Figure 4 shows a more detailed analysis of the average
number of hydroxylations. In Figure 4A, the average number
of hydroxylations per peptide per tissue is shown. The overall
average numbers of hydroxylations in CRC and CRLM are
significantly lower than those in colon and liver tissue. Liver
and colon tissue do not differ in number of hydroxylations,
and also CRC and CRLM do not differ in this respect.
Figure 4B shows the differences in the average number of
hydroxylations in the comparison of colon tissue and the
other tissues investigated. Figure 4B visualizes the overall shift
in the average number of hydroxylations per peptide. The
overall shift in the number of hydroxylations per peptide in
liver tissue, with respect to colon tissue, does not significantly
differ from zero. Overall, the mean of all average number of
hydroxylations per peptide is significantly downregulated in CRC
(p = 6.3∗10−3) and in CRLM (p = 6.3∗10−5) tissue compared
to liver tissue. CRC and CRLM do not have a different shift
in comparison to each other (p = 0.27). In Figure 4C, the
relative differences in the average with respect to colon tissue
are shown. There is a significant decrease in the average degree
of hydroxylation, on average −9% in CRC (SD = 14%, p
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FIGURE 3 | 2D-PCA-plot showing the separation of all 4 tissue types based on their degree of hydroxylation. The x-axis is the first principal component (PC1) of the
PCA, which explains 19.1% of the variation. The y-axis is the second principal component (PC2) of the PCA, which explains 9.1% of the variation.
= 0.00056), and on average −12% in CRLM (SD = 22%, p
= 0.0026) with respect to colon tissue, and liver tissue does
not significantly differ from colon tissue (average = −3%,
SD= 27%, p= 0.55).
Figure 4C visualizes how the degree of hydroxylation changes
per peptide from colon to CRC, to CRLM, to liver tissue.
For peptide 1, the average number of hydroxylations remains
constant with the transition from colon to CRC tissue. However,
in CRLM tissue the average number of hydroxylations decreases
strongly. The degree of hydroxylation of peptide 1 in CRLM is
similar to that in liver tissue. Regarding peptide 21, the average
number of hydroxylations decreases strongly from colon to CRC,
and from CRC to CRLM, and is fairly similar between CRLM and
liver tissue. Regarding peptides 15 and 16, the average number of
hydroxylations decreases from colon to CRC, and increases from
CRC to CRLM to liver tissue. Peptides 1, 15, 16, and 21 appear
to move toward liver tissue, when transitioning from colon, via
CRC, to CRLM.
The largest number (n = 30) of different specific
hydroxylation sites were detected between liver and colon
tissue; a comparable number (n = 27) of different specific
hydroxylation sites is present between colon and CRLM tissue.
A closer study of specific hydroxylations that differ between
liver and CRLM tissue, shows several unique differences, see
Table 1. Peptide 7 with 0 hydroxylations is more prevalent
in CRC and CRLM than in healthy colon and liver tissue.
Peptide 13 with 1, peptide 15 with 1, peptide 16 with 1,
peptide 18 with 0, peptide 19 with 3, and peptide 34 with
2 hydroxylations are abundantly present in colon, CRC and
CRLM, but hardly in liver tissue. Peptide sequences are
presented in the Supplementary S5, S6. Peptide 17 with 2, and
peptide 27 with 5 hydroxylation are less abundant in CRLM
compared to colon, CRC, and liver. Peptide 14 with 6, and
peptide 24 with 5 hydroxylations, are present at similar levels
in colon and liver, less in CRC, and the least in CRLM. The
general pattern emerging from this data is consistent with
a lower degree of hydroxylation in CRLM than in liver or
colon tissue.
Urine Analysis
In urine, natural occurring peptides (NOPs) were identified that
overlap with six peptides from 1 (21). Only for peptide 34,
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FIGURE 4 | (A) The average number of hydroxylations per peptide. Tested for differences with a repeated paired t-test. P-values below 0.05/6 = 0.0083 are
considered significant. (B) Absolute difference in the average number of hydroxylations per peptide with respect to colon tissue. P-values below 0.05/3 = 0.0167 are
considered significant. (C) Relative difference in the number of hydroxylations with respect to colon tissue. The “X” in the legend of the Y-axis represents CRC, CRLM,
or liver tissue, depending on the comparison made. Only significant values are presented as horizontal bars in (A) and (B).
TABLE 1 | Peptides with a specific hydroxylation form that are significantly different between liver and CRLM tissue, and the number of patients, per tissue, in whom the
peptide was identified.
Peptide Number of
prolines and
lysines
Number of
hydroxylations
14 Patients
(matching colon, CRC, liver, and CRLM)
30 Patients
(matching liver, and CRLM)
Colon CRC CRLM Liver CRLM Liver
7 7 0 0 2 8 0 15 0
13 4 1 14 14 12 3 26 13
14 8 6 13 7 3 14 5 27
15 5 1 14 14 12 3 26 6
16 9 2 13 13 8 1 20 3
17 4 2 14 10 4 11 10 18
18 4 0 7 9 11 1 26 3
19 6 3 8 11 11 0 22 3
24 9 5 5 3 0 8 2 13
27 9 5 13 12 3 9 5 17
34 9 2 12 11 10 0 20 2
from 1, a NOP (AGPPGAPGAPGAPGPVGPAGKSGDRGETGP
with 2 hydroxylations) was significantly different (p-value of
3.1∗10−4) between urine from patients suffering from CRLM
and healthy control urine. On the basis of the b- and y-
ions from MS/MS spectra, the peptide AGPP(-OH)GAP(-
OH)GAPGAPGPVGPAGKSGDRGETGP is identified to be
hydroxylated at the 5th and 8th amino acid in colon tissue,
CRC tissue, liver tissue, CRLM tissue, control urine, and
CRLM urine.
DISCUSSION
The hydroxylation pattern of collagen alpha-1(I) is tissue-specific
and each studied tissue has a unique hydroxylation pattern and
a degree of hydroxylation as could be detected by PCA and
statistical analysis. The variation in the hydroxylation pattern
between liver and colon is larger than the variation within
each tissue. Even though the average number of hydroxylations
is comparable between colon and liver tissue, locally along
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the collagen alpha-1(I) chain the degree of hydroxylation is
significantly different. The variation within a tissue and between
healthy tissues implicates that every collagen triple helix has
a unique hydroxylation pattern. Further studies are required
to investigate whether prolines at specific sites are always
hydroxylated. In addition, it would be of interest to ascertain
whether a lack of specific hydroxyprolines could inhibit triple
helix formation, or prevent incorporation of such a triple helix
into supra-molecular structures. The hydroxylation pattern has
a strong influence on the Tm. We suggest that every triple
helix consequently has a slightly different Tm, and therefore
interacts differently with the surroundings, and has different
micro-unfoldings. In previous research it has been assumed that
all prolines are hydroxylated; for example, to determine the Tm
in silico (23). We show that this is not the case and that this
assumption leads to an overestimation of the Tm.
The collagen hydroxylation pattern is studied based on 36
selected peptides. Several of these selected peptides contain
a missed cleavage present at arginine at lysine. A possible
explanation is the presence of hydroxylation at the lysine moiety,
which has been described to reduce the activity of trypsin (24).
Although, peptide 1, which only contains one lysine moiety,
is observed with and without a hydroxylation at lysine. This
example shows that trypsin is able to cleave at a hydroxylated
lysine. It might be more likely that the presence of aspartic acid
and glutamic acid in close proximity to an arginine and lysine
moiety reduces the efficiency of trypsin activity (25, 26).
We investigated if the hydroxylation pattern in a tumor
migrates with the metastasis. The results of this study indicate
that the hydroxylation degree in tumor tissue decreases
significantly in comparison to degree of hydroxylation in healthy
tissue. The degree of hydroxylation in CRC tissue is 9% lower
and that in CRLM is 12% lower than in colon and liver
tissue. Still, in the comparisons “colon vs. liver” and “CRLM vs.
CRC” similar numbers of peptides were down- and upregulated.
The hydroxylation pattern of several of the studied peptides
appears to be tissue-dependent. For instance, peptide 1 was
present in colon tissue with 0 and 1 hydroxylation, but in
liver tissue only with 0 hydroxylation. CRLM tissue seems to
be in an intermediate state, containing both peptide 1 with
0 hydroxylation and—to a lesser extent—peptide 1 with 1
hydroxylation. Peptide 1 contains just one lysine moiety, and
zero proline moieties, further modification of 5-hydroxylysine
(e.g., glycosylation) can prevent detection of peptide 1 with 1
hydroxylation. To our knowledge additional modifications of
this specific lysine are not described in literature; nevertheless,
if an additional modification is present, then this still indicates
a significant difference between the tissues that have been
compared. In line with the peptide 1 pattern, the hydroxylation
degree of peptide 21 in colon tissue is similar to that in CRC
tissue, and strongly reduced in both CRLM and liver tissue. The
hydroxylation degree of peptides 15 and 16 decreases in CRC
tissue, increases in CRLM tissue, and is even higher in liver tissue.
Despite the reduced degree of hydroxylation in CRLM tissue, the
general hydroxylation pattern does partly resemble liver tissue
but also CRC, and colon.
A recently described method to detect CRLM is by measuring
collagen natural occurring peptides (NOPs) in urine (27, 28).
Higher sensitivity and specificity can potentially be obtained
by adding distinctive collagen NOPs to the panel of molecular
markers as described by us. In the present study, we found
an overall reduction in the degree of collagen hydroxylation in
tumor tissue, and identified specific peptides which are distinctive
between CRLM and liver tissue. Comparison with previous data
(21) showed that a NOP, which overlaps with peptide 34, was
significantly different in urine of patients suffering from CRLM
and in urine of healthy controls. This NOP is a promising
candidate to improve the detection of CRLM in urine. Especially,
because this peptide shows a biologically relation to the liver
metastasis tumor. If the degree of collagen hydroxylation is
too low, then the Tm of the formed triple helix can be too
low and as a result this collagen will not be built into the
supramolecular structures. Consequently we may find that there
is a possibility to find NOPs in urine that have an even lower
degree of hydroxylation than observed in this study, which could
possibly be even more distinctive.
Hypoxia is a possible explanation of the overall decreased
degree of hydroxylation in tumor tissue. McKeown clarified
differences in the partial pressure of oxygen (pO2) in healthy and
tumor tissue (29). The pO2 in rectal cancer tissue (30mm Hg)
is ∼2 times lower than in healthy rectal tissue (52 mmHg); the
pO2 in liver tumor (6.0 mmHg) is∼5 times lower than in healthy
liver tissue (30 mmHg). Utting et al. (16) showed that hypoxia
reduces the degree of hydroxylation and has the largest effect
on Hyl formation, and a relative small effect on Hyp formation.
In contrast to the above reasoning, the hydroxylation degree of
peptides 1 and 21 is decreased in liver tissue in comparison to
colon tissue. Peptide 15 and 16, also in contrast to the overall
trend, have an increasing hydroxylation degree from CRC to
CRLM to liver tissue. Hypoxia can explain the general trend
observed, although specific cases such as peptides 1, 15, 16, and 21
do not agree with these observations of McKeown en Utting et al.
(16) and may be explained by unknown mechanisms by which
hydroxylation is regulated specifically.
Proline and lysine can be enzymatically hydroxylated. Van
Huizen et al. (20) described the general upregulation of enzymes
related to collagen production and hydroxylation in CRLM.
Except the specific enzyme P4HB, the beta unit of 4-prolyl
hydroxylase, is strongly reduced in CRLM (11, SD = 5 unique
peptides) compared to liver tissue (20, SD = 5 unique peptides)
(fold change = 0.48, p = 1.6∗10−18). P4HB is crucial for the
solubility and folding of 4-prolyl hydroxylase. In the present
study in colon tissue, on average, 12.8 peptides (SD = 4.1)
belonging to P4HB were identified, and in CRC on average 16.1
peptides (SD = 3.9). The downregulation of P4HB in CRLM in
comparison to liver tissue might explain the decreased degree of
hydroxylation; in CRC tissue, however, P4HB is higher than in
colon tissue while the hydroxylation degree is also decreased.
The extracellular matrix is involved in tumor development
(30). It has been proposed that the extracellular matrix can
act as a tumor suppressor as long as it remains in its’natural
shape’; if the “natural morphology” is lost, then it could become
a tumor promoter (30). In this study we have shown that
besides the collagen expression, also the collagen hydroxylation is
significantly different between tumor and normal tissue. Further
research is required to understand the effect of the reduced degree
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of collagen hydroxylation on tumor proliferation and to identify
the mechanisms that are involved in the regulation of changed
hydroxylation levels in cancer.
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